RESUMEN
Extended-Spectrum-Cephalosporin (ESC)-resistant Enterobacteriaceae have widely spread in all settings worldwide. In animals, Extended-Spectrum Beta-Lactamase (ESBL) producers have been frequently identified in veal calves. The objectives of this study were to investigate the trends in the ESBL load and antimicrobial resistance (AMR) proportions, and antimicrobial usages (AMU) in veal calves during the fattening process. Ten fattening farms were selected and 50 animals per farm were sampled. AMR was assessed in bacteria from the dominant flora (collected on non-selective MacConckey agar) and in ESBL/AmpC-carrying bacteria from the subdominant flora (selected on ChromID ESBL selective plates) upon arrival and 5-6 months later before slaughter. The number and types of treatments during fattening were also collected. Rates of ESBL-producing E. coli from the subdominant flora significantly decreased in all farms (arrival: 67.7%; departure: 20.4%) whereas rates of multidrug-resistant E. coli from the dominant flora have significantly increased (arrival: 60.2%; departure: 67.2%; p = 0.025). CTX-M-1 was the most frequently identified ESBL enzyme (arrival: 59.3%; departure: 52.0%). The plasmid-mediated mcr-1 gene was also identified occasionally. In parallel, levels of resistances to non-critically important antimicrobials were already high upon arrival but have still further increased over time until slaughter. Our study also highlighted that if only ESBL-producing isolates were monitored, it might have led to a partial (and partly false) picture of AMR rates globally decreasing during the fattening period. The mean number of antimicrobial treatments per calf (NTPC) was 8.75 but no association between AMU and AMR was evidenced. Most ESBL producers were clonally unrelated suggesting multiple sources and not cross-contaminations among calves during transportation. Feeding milk containing antimicrobial residues to veal calves is hypothesized to explain the high ESBL loads in animals at the entrance on farms.
RESUMEN
Replacement of skim milk proteins by solubilized wheat protein (SWP) in milk replacers for veal calves would contribute to the reduction in feeding costs. The occurrence of metabolic disorders has, however, been reported. Forty-two male calves received one of three treatments over 140 days: a control diet, a diet containing SWP without or with branched-chain amino acid supplementation. Liveweight gain, carcass yield, color and conformation did not show any significant differences. No metabolic disorders were noted. Supplementation with branched-chain amino acids reduced the marginal Val deficiency but did not modify the growth performances. With the SWP containing diets, the plasma metabolite profile was characteristic of those observed with non-clotting diets. It was statistically correlated to the changes in the orientation of the Semitendinosus muscle energy metabolism towards a more oxidative type and to indications of a lower efficiency of amino acid utilisation for protein deposition. At the present levels of inclusion, SWP proved to be an interesting alternative to the sole use of whey as the protein source in milk replacers for veal calves.
